ARTICLE | Finance
Ebb & Flow
March 15, 2010 7:00 AM UTC
IB Australian Biosciencecapitalized on a nice return from a 2008 fund to launch a new Asia-Pacific healthcare fund with a maximum fund size of A$200 million ($181.4 million).
The venture fund will invest in healthcare and medical science companies in the region, including in China, India and Japan...